Daily Archives: October 28, 2020

COVID-19: When will FDA convene an independent advisory committee for monoclonal antibody EUAs?  

By on .

By Daniel R. Lucey M.D., MPH, FIDSA Rapidly evolving events regarding studies of monoclonal antibodies reemphasize the call first made here Oct. 19  that the U.S. Food and Drug Administration convene an outside expert advisory committee ASAP to advise on requests for Emergency Use Authorization for monoclonal antibodies against SARS-CoV-2. On Oct. 7 Lilly announced […]